Correction: Zheng et al. Glycolysis-Related SLC2A1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy. Cancers 2022, 14, 5344

Cancers (Basel). 2023 Jan 18;15(3):586. doi: 10.3390/cancers15030586.

Authors

Haosheng Zheng¹, Guojie Long^{2

3}, Yuzhen Zheng¹, Xingping Yang¹, Weijie Cai¹, Shiyun He¹, Xianyu Qin¹, Hongying Liao¹

Affiliations

¹ Department of Thoracic Surgery, Thoracic Cancer Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
² Guangdong Research Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou 510655, China.
³ Department of Pancreatic Hepatobiliary Surgery, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, China.

Abstract

The authors wish to make the following corrections to this paper [...].

Publication types

Published Erratum